title: Role of selegiline in combination therapy of Parkinson's disease.
authors.affiliation: Department of Neurology, University of Oulu, Finland.
authors.forename: V V
authors.initials: VV
authors.lastname: Myllylä
authors.forename: K
authors.initials: K
authors.lastname: Sotaniemi
authors.forename: O
authors.initials: O
authors.lastname: Mäki-Ikola
authors.forename: U K
authors.initials: UK
authors.lastname: Rinne
authors.forename: E H
authors.initials: EH
authors.lastname: Heinonen
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa